0002-7026 : Jaypirca 100 mg Oral Tablet, Coated


NDC: 0002-7026
Labeler: Eli Lilly and Company
Product Type: Human Prescription Drug
Drug Name:  Jaypirca
Dosage Form: Oral Tablet, Coated
Application #: NDA216059
Rev. Date: 


NDC Package Codes:

  • 0002-7026-60: 60 TABLET, COATED IN 1 BOTTLE (0002‑7026‑60)
  • 0002-7026-99: 30 TABLET, COATED IN 1 BOTTLE (0002‑7026‑99)

Active Ingredients:

  • Pirtobrutinib

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Bruton's Tyrosine Kinase Inhibitors [MoA]
  • Cytochrome P450 2C19 Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Kinase Inhibitor [EPC]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0002-6902 Jaypirca 50 mg Oral Tablet, Coated by Eli Lilly and Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0002-7026 QR Code

< Prev: 0002-6902Next: 0002-7140 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.